YPYoung Hwan Park

Young Hwan Park

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Young Hwan Park has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Preparation of scaffolds based on bulky sutures for cell therapy

    by Young Hwan Park, Heung Jae Chun, Sung Jin Kim

    Scaffold for cell therapy was prepared with poly (lactide-co-glicolide, PLA/PGA (10:90). By using melt-spinning and draw texturing process, we could prepare microfibrous bulky suture which had heterogeneous macropore. Microfibrous structure has great potentiality as biomimicking architecture for cell growth and maintaining cell functions. The result of cell seeding showed that pore size, pore distribution, and fiber fineness of sutures were suitable as a biocompatible scaffold in vitro for NIH 3T3 Fibroblast cell. Also, we expect that prepared scaffold for cell-therapy will provide numerous benefits as a noninvasive alternative for tissue engineering applications.


  • Open Access

    In Vivo Biocompatibility Study of Electrospun Chitosan Microfiber for Tissue Engineering

    by Yun Mi Kang, Bit Na Lee, Jae Hoon Ko, Gyeong Hae Kim, Kkot Nim Kang, Da Yeon Kim, Jae Ho Kim, Young Hwan Park, Heung Jae Chun, Chun Ho Kim, et al.

    In this work, we examined the biocompatibility of electrospun chitosan microfibers as a scaffold. The chitosan microfibers showed a three-dimensional pore structure by SEM. The chitosan microfibers supported attachment and viability of rat muscle-derived stem cells (rMDSCs). Subcutaneous implantation of the chitosan microfibers demonstrated that implantation of rMDSCs containing chitosan microfibers induced lower host tissue responses with decreased macrophage accumulation than did the chitosan microfibers alone, probably due to the immunosuppression of the transplanted rMDSCs. Our results collectively show that chitosan microfibers could serve as a biocompatible in vivo scaffold for rMDSCs in rats.